法国已正式批准一款名为Poppins的视频游戏纳入医保报销范围，该游戏旨在为患有阅读障碍（dyslexie）的儿童提供辅助治疗。这一决定标志着数字疗法在法国公共卫生体系中的进一步认可，也为相关技术创新开辟了新的应用空间。Poppins通过游戏化的方式，帮助儿童改善阅读与语言能力，其疗效此前已通过临床验证。此次获准报销，意味着符合条件的家庭可经由医生处方获得该游戏，并享受医保资金支持。这一举措不仅降低了患者家庭的经济负担，也反映出法国政府对数字健康解决方案的积极态度，为后续同类产品的审批和推广提供了参照。报道首发于Maddyness。
帮助阅读障碍儿童的视频游戏Poppins获准报销。
Feu vert pour le remboursement de Poppins, le jeu vidéo qui vient en aide aux enfants dyslexiques
摘要
法国卫生机构批准了针对阅读障碍儿童的电子游戏Poppins的医保报销，该游戏由同名公司开发。这一决定标志着数字疗法在儿童学习障碍领域获得正式认可，并将推动其商业化和普及。
法国卫生机构批准了针对阅读障碍儿童的电子游戏Poppins的医保报销，该游戏由同名公司开发。这一决定标志着数字疗法在儿童学习障碍领域获得正式认可，并将推动其商业化和普及。
Summary
Poppins, a video game designed to assist dyslexic children, has received regulatory approval for reimbursement in France. This decision, reported by Maddyness, marks a significant step for the digital therapeutic, enabling wider access through health insurance coverage and validating the use of gaming technology for educational and cognitive support.
Poppins, a video game designed to assist dyslexic children, has received regulatory approval for reimbursement in France. This decision, reported by Maddyness, marks a significant step for the digital therapeutic, enabling wider access through health insurance coverage and validating the use of gaming technology for educational and cognitive support.
Poppins, a French digital therapeutic in the form of a video game, has secured reimbursement approval from the national health authority (Haute Autorité de Santé, HAS), marking a milestone for the medtech startup. The game targets children aged 7 to 11 with specific written language disorders, commonly known as dyslexia, and will now be partially or fully covered by the French social security system, ending a two-year wait since the company filed its dossier.
Founded in 2019, Poppins developed the eponymous mobile application that combines rhythmic musical exercises with a video game interface to retrain brain connectivity underlying reading difficulties. The therapy spans six months, with daily sessions of approximately 20 minutes, and is designed to be used at home under parental supervision. Clinical studies conducted with Paris hospitals demonstrated significant improvements in reading speed and accuracy, with gains maintained over time, reinforcing its CE-marked medical device status.
The HAS decision represents a critical step toward scaling access: the therapy will be available through prescription by healthcare professionals, integrating it into the standard care pathway for dyslexia. Pricing details remain under discussion with the Economic Committee for Health Products (CEPS), but the company expects broad adoption by the end of 2024. CEO and co-founder Anne-Laure Le Cardinal highlighted the decision as a victory for families who previously faced out-of-pocket costs of several hundred euros for the program, noting that reimbursement will remove a significant barrier to treatment.
The approval also positions Poppins as one of the first digital therapeutics reimbursed in France, signaling a growing acceptance of evidence-based, software-driven interventions in public health. The company plans to expand its therapeutic offerings to other neurodevelopmental disorders, leveraging the same rhythm-based platform. The move aligns with France’s push for innovation in healthcare, encouraging other digital health startups to pursue clinical validation and regulatory pathways.
Résumé
Le jeu vidéo thérapeutique Poppins, destiné à aider les enfants dyslexiques, a reçu le feu vert des autorités de santé pour un remboursement par l’Assurance Maladie. Cette reconnaissance officielle valide son efficacité clinique et facilite l’accès à cette solution numérique pour les familles, tout en renforçant le modèle économique des thérapies digitales.
Le jeu vidéo thérapeutique Poppins, destiné à aider les enfants dyslexiques, a reçu le feu vert des autorités de santé pour un remboursement par l’Assurance Maladie. Cette reconnaissance officielle valide son efficacité clinique et facilite l’accès à cette solution numérique pour les familles, tout en renforçant le modèle économique des thérapies digitales.
L’article Feu vert pour le remboursement de Poppins, le jeu vidéo qui vient en aide aux enfants dyslexiques est apparu en premier sur Maddyness - Le média pour comprendre l'économie de demain.
Core Point
French health authorities have approved reimbursement for Poppins, a video game designed to help dyslexic children, marking a pioneering step in recognizing digital therapeutics as legitimate medical interventions.
Key Players
Poppins — develops a therapeutic music-based video game for children with dyslexia, based in Paris, France.
Industry Impact
- ICT: Medium — sets a reimbursement precedent for digital health apps, encouraging innovation and investment in software-based medical treatments.
Tracking
Strongly track — as the first reimbursed video game therapy in France, this decision could catalyze a broader shift toward formal recognition and funding of digital therapeutics.